awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38567540-09F2C6E8-96E4-4781-BBC1-9DE2CEB2300D
Q38567540-09F2C6E8-96E4-4781-BBC1-9DE2CEB2300D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38567540-09F2C6E8-96E4-4781-BBC1-9DE2CEB2300D
Setting Appropriate Goals for the Next Generation of Clinical Trials in Myelofibrosis.
P2860
Q38567540-09F2C6E8-96E4-4781-BBC1-9DE2CEB2300D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38567540-09F2C6E8-96E4-4781-BBC1-9DE2CEB2300D
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
efeb6022f7132f20baa136677f93e71233d2d03f
P2860
Dual PI3K/AKT/mTOR inhibitor BEZ235 synergistically enhances the activity of JAK2 inhibitor against cultured and primary human myeloproliferative neoplasm cells.